Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

216.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 237.00
  • 52 Week Low: 176.60
  • Currency: UK Pounds
  • Shares Issued: 219.46m
  • Volume: 230,727
  • Market Cap: £475.13m
  • RiskGrade: 156

AMS Overview

We are a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on value for our customers and quality outcomes for patients.
Competitors: Convatec Group, Consort Medical
Registrars: Capita Registrars

Key Personnel

CEO: A Christopher (Chris) Meredith
CFO: Eddie Johnson
Independent Non-Executive Director: Douglas Le Fort
Non-Executive Chairman: Grahame Cook
Senior Independent Director: Susan Searle
Non-Executive Dir: Juliet Thompson

Contact Details

Address: Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, United Kingdom, CW7 3RT
Phone: +44 (0) 1606 863500
Fax: +44 (0) 1606 863600
Website: http://www.admedsol.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0004536594

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 216.50p
Change Today 0.50p
% Change 0.23 %
52 Week High 237.00
52 Week Low 176.60
Volume 230,727
Shares Issued 219.46m
Market Cap £475.13m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.64% below the market average92.64% below the market average92.64% below the market average92.64% below the market average92.64% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Price Trend
42.22% below the market average42.22% below the market average42.22% below the market average42.22% below the market average42.22% below the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average
Income
84.64% below the market average84.64% below the market average84.64% below the market average84.64% below the market average84.64% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Growth
16.16% below the market average16.16% below the market average16.16% below the market average16.16% below the market average16.16% below the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 0
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Interim Final
Ex-Div 25-Sep-25 19-Jun-25
Paid 24-Oct-25 17-Jul-25
Amount 0.85p 1.83p

Trades for 05-Nov-2025

Time Volume / Share Price
12:18 2,250 @ 216.28p
12:11 1,354 @ 216.50p
12:11 114 @ 216.50p
12:11 940 @ 216.50p
12:11 1,538 @ 216.00p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson

Top of Page